Observational studyThe oncologist2026

Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.

Daisuke Kotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.